139 related articles for article (PubMed ID: 21858442)
1. Pulmonary alveolar hemorrhage possibly associated with lenalidomide use.
Oshima Y; Tojo A
Int J Hematol; 2011 Sep; 94(3):296-297. PubMed ID: 21858442
[No Abstract] [Full Text] [Related]
2. Diffuse alveolar hemorrhage associated with lenalidomide.
Sakai M; Kubota T; Kuwayama Y; Ikezoe T; Yokoyama A
Int J Hematol; 2011 Jun; 93(6):830-831. PubMed ID: 21573890
[No Abstract] [Full Text] [Related]
3. Successful re-administration of lenalidomide after lenalidomide-induced pulmonary alveolar hemorrhage in a patient with refractory myeloma.
Sakai M; Kubota T; Takaoka M; Tsukuda T; Arakawa Y; Anabuki K; Ikezoe T; Togitani K; Yokoyama A
Ann Hematol; 2015 May; 94(5):891-2. PubMed ID: 25407112
[No Abstract] [Full Text] [Related]
4. Bortezomib-related diffuse alveolar hemorrhage.
Wirk B
J Clin Oncol; 2012 Dec; 30(36):e379-81. PubMed ID: 23150703
[No Abstract] [Full Text] [Related]
5. How to prevent deep vein thrombosis in myeloma patients receiving thalidomide or lenalidomide.
Kastritis E; Dimopoulos M
Leuk Lymphoma; 2007 Dec; 48(12):2295-7. PubMed ID: 18066998
[No Abstract] [Full Text] [Related]
6. Reversible pulmonary toxicity due to lenalidomide.
Coates S; Barker A; Spurgeon S
J Oncol Pharm Pract; 2012 Jun; 18(2):284-6. PubMed ID: 21742815
[TBL] [Abstract][Full Text] [Related]
7. [Lenalidomide; adverse effects and commercialisation].
Ortega Valín L; del Pozo Ruiz JJ; Rodríguez Lage C; Ramos Ortega F
Farm Hosp; 2008; 32(6):358-60. PubMed ID: 19232222
[No Abstract] [Full Text] [Related]
8. Amiodarone and diffuse alveolar hemorrhage.
Papanikolaou IC; Makou I; Markatis E
Adv Respir Med; 2020; 88(2):169-171. PubMed ID: 32383473
[No Abstract] [Full Text] [Related]
9. Drug-induced interstitial pneumonitis due to low-dose lenalidomide.
Kunimasa K; Ueda T; Arita M; Maeda T; Hotta M; Ishida T
Intern Med; 2012; 51(9):1081-5. PubMed ID: 22576392
[TBL] [Abstract][Full Text] [Related]
10. Interstitial pneumonitis associated with the immunomodulatory drugs thalidomide and lenalidomide.
Iino M
Int J Hematol; 2012 Feb; 95(2):223-4. PubMed ID: 22198829
[No Abstract] [Full Text] [Related]
11. [Diffuse alveolar hemorrhage after hematopoietic stem cell transplantation].
Mo XD; Huang XJ
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):216-9. PubMed ID: 23856148
[No Abstract] [Full Text] [Related]
12. Lenalidomide-associated hypothyroidism.
Menon S; Habermann T; Witzig T
Leuk Lymphoma; 2007 Dec; 48(12):2465-7. PubMed ID: 18067027
[No Abstract] [Full Text] [Related]
13. Lenalidomide-associated hemolytic anemia.
Lim MY; Raval JS; Richards KL; Zeidner JF; Foster MC
Leuk Lymphoma; 2015; 56(9):2717-9. PubMed ID: 25644743
[No Abstract] [Full Text] [Related]
14. [Diffuse alveolar hemorrhage in a cannabis smoker].
Klotz T; Martin D
Rev Prat; 2009 Jun; 59(6):758. PubMed ID: 19642428
[No Abstract] [Full Text] [Related]
15. Lenalidomide-induced acute interstitial nephritis.
Lipson EJ; Huff CA; Holanda DG; McDevitt MA; Fine DM
Oncologist; 2010; 15(9):961-4. PubMed ID: 20709889
[TBL] [Abstract][Full Text] [Related]
16. Lenalidomide induced intrahepatic cholestasis in newly diagnosed patients of multiple myeloma.
Jena RK; Swain TR; Kansurkar SS; Swain M
Eur J Clin Pharmacol; 2012 May; 68(5):881-4. PubMed ID: 22127618
[TBL] [Abstract][Full Text] [Related]
17. Metastatic renal cell carcinoma complicated with diffuse alveolar hemorrhage: a rare adverse effect of sunitinib.
Yamada T; Ohtsubo K; Izumi K; Takeuchi S; Mouri H; Yamashita K; Yasumoto K; Ghenev P; Kitagawa S; Yano S
Int J Clin Oncol; 2010 Dec; 15(6):638-41. PubMed ID: 20602135
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myeloma.
Niesvizky R; Martínez-Baños D; Jalbrzikowski J; Christos P; Furst J; De Sancho M; Mark T; Pearse R; Mazumdar M; Zafar F; Pekle K; Leonard J; Jayabalan D; Coleman M
Leuk Lymphoma; 2007 Dec; 48(12):2330-7. PubMed ID: 18067007
[TBL] [Abstract][Full Text] [Related]
19. Fatal diffuse alveolar hemorrhage associated with sirolimus after allogeneic hematopoietic cell transplantation.
Patel AV; Hahn T; Bogner PN; Loud PA; Brown K; Paplham P; Syta M; Battiwalla M; McCarthy PL
Bone Marrow Transplant; 2010 Aug; 45(8):1363-4. PubMed ID: 19966843
[No Abstract] [Full Text] [Related]
20. Lenalidomide-induced cytokine release syndrome in a patient with multiple myeloma.
Nakamura N; Kanemura N; Shibata Y; Matsumoto T; Mabuchi R; Nakamura H; Kitagawa J; Goto N; Hara T; Tsurumi H; Moriwaki H
Leuk Lymphoma; 2014 Jul; 55(7):1691-3. PubMed ID: 24138307
[No Abstract] [Full Text] [Related]
[Next] [New Search]
